Humedix Co., Ltd. (KOSDAQ:200670)
South Korea · Delayed Price · Currency is KRW 25,650
-300 (-1.16%)
Oct 8, 2026, 3:30 PM KST
Humedix Market Cap
Humedix has a market cap or net worth of 264.71 billion as of October 9, 2026. It is the 21,023rd most valuable company in the world and the 723rd biggest in South Korea. Its market cap has decreased by 49.90% in one year.
Market Cap
264.71B
Enterprise Value
n/a
Revenue
110.99B
Global Rank
Country Rank
#723 South Korea
PE Ratio
26.61
ChartMarket Cap Chart
Since December 26, 2014, Humedix's market cap has increased from 223.01B to 264.71B, an increase of 18.70%. That is a compound annual growth rate of 1.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 264.71B | -36.43% |
| Dec 30, 2025 | 416.42B | -4.39% |
| Dec 30, 2024 | 435.54B | 24.67% |
| Dec 28, 2023 | 349.36B | 38.28% |
| Dec 29, 2022 | 252.65B | 12.18% |
| Dec 30, 2021 | 225.21B | -0.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dong-A ST | 336.87B |
| EuBiologics | 309.45B |
| JW Holdings | 284.03B |
| Korea United Pharm | 255.22B |
| Samjin Pharmaceuticals | 246.38B |
| Suheung | 225.51B |
| AptaBio Therapeutics | 223.06B |
| Huons | 221.38B |